Sean McCutcheon
Stock Analyst at Raymond James
(n/a)
# 4,649
Out of 4,876 analysts
5
Total ratings
n/a
Success rate
-48.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENGN enGene Holdings | Initiates: Outperform | $23 | $3.66 | +528.42% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $8.14 | +391.40% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $33.16 | +111.10% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $34.63 | +148.34% | 1 | Mar 13, 2024 |
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $3.66
Upside: +528.42%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $8.14
Upside: +391.40%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $33.16
Upside: +111.10%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $34.63
Upside: +148.34%